Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) EBIT (2020 - 2025)

P3 Health Partners (PIII) has disclosed EBIT for 6 consecutive years, with -$44.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT rose 58.67% year-over-year to -$44.2 million, compared with a TTM value of -$333.4 million through Sep 2025, down 52.23%, and an annual FY2024 reading of -$320.7 million, down 90.95% over the prior year.
  • EBIT was -$44.2 million for Q3 2025 at P3 Health Partners, down from -$34.1 million in the prior quarter.
  • Across five years, EBIT topped out at -$13.0 million in Q1 2021 and bottomed at -$912.2 million in Q2 2022.
  • Average EBIT over 5 years is -$128.5 million, with a median of -$44.0 million recorded in 2024.
  • The sharpest move saw EBIT plummeted 3412.32% in 2022, then skyrocketed 97.69% in 2023.
  • Year by year, EBIT stood at -$62.0 million in 2021, then tumbled by 765.75% to -$536.5 million in 2022, then skyrocketed by 93.13% to -$36.9 million in 2023, then crashed by 488.41% to -$217.0 million in 2024, then surged by 79.62% to -$44.2 million in 2025.
  • Business Quant data shows EBIT for PIII at -$44.2 million in Q3 2025, -$34.1 million in Q2 2025, and -$38.1 million in Q1 2025.